Targeting CBL ubiquitin ligase activation to downregulate tyrosine kinase signalling
This study demonstrates that engineering a CBL mutant to mimic SLAP2-mediated activation enhances EGFR ubiquitination and degradation, thereby attenuating tyrosine kinase signaling, and validates a small-molecule screening approach to pharmacologically target this mechanism for therapeutic downregulation of tyrosine kinase pathways.